Clinical-Stage Platforms
Part of Biotech - Drug Development
 TMO | Thermo Fisher Scientific, Inc. | $242.1b | $659.00 | -2.6% | 2.3M |
 A | Agilent Technologies Inc. | $47.3b | $168.45 | -1.1% | 1.5M |
 IQV | IQVIA Holdings Inc. | $42.5b | $259.45 | -2.3% | 840.5K |
 WAT | Waters Corp | $41.8b | $436.90 | -0.8% | 912.0K |
 WST | West Pharmaceutical Services, Inc. | $25.7b | $373.13 | -1.1% | 286.1K |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $25.5b | $56.43 | -0.4% | 2.0M |
 RVTY | Revvity, Inc. | $16.9b | $151.34 | -3.3% | 2.2M |
 MEDP | Medpace Holdings, Inc. Common Stock | $16.7b | $601.50 | -2.8% | 174.7K |
 ASND | Ascendis Pharma A/S Ordinary Share | $15.0b | $226.31 | -0.8% | 854.1K |
 CRL | Charles River Laboratories International, Inc. | $13.9b | $310.00 | -1.9% | 1.6M |
 TWST | Twist Bioscience Corporation Common Stock | $12.5b | $167.10 | -18.6% | 7.3M |
 ICLR | Icon Plc | $12.5b | $161.71 | -3.9% | 875.3K |
 HALO | Halozyme Therapeutics, Inc. | $12.5b | $109.11 | +1.3% | 1.5M |
 TECH | Bio-Techne Corp. | $11.4b | $72.44 | -0.2% | 2.7M |
 AVTR | Avantor, Inc. | $10.4b | $15.46 | -2.4% | 9.8M |
 RGEN | Repligen Corp | $10.3b | $175.00 | -7.7% | 1.3M |
 BRKR | Bruker Corporation | $9.6b | $60.56 | -5.3% | 2.5M |
 QGEN | QIAGEN N.V. | $9.2b | $47.00 | -0.3% | 2.6M |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $8.9b | $106.06 | -3.6% | 771.3K |
 LGND | Ligand Pharmaceuticals Inc. | $6.0b | $287.37 | -3.1% | 125.8K |
 CGON | CG Oncology, Inc. Common stock | $6.0b | $63.65 | -7.4% | 532.0K |
 KOD | Kodiak Sciences Inc Common Stock | $5.9b | $92.86 | -1.7% | 1.4M |
 MANE | Veradermics, Incorporated | $4.9b | $109.97 | -8.3% | 668.3K |
 ABCL | AbCellera Biologics Inc. Common Shares | $4.5b | $13.26 | -4.6% | 9.5M |
 RLAY | Relay Therapeutics, Inc. Common Stock | $4.2b | $18.60 | -3.3% | 3.2M |
 OGN | Organon & Co. | $3.6b | $13.66 | +0.3% | 1.7M |
 CELC | Celcuity Inc. Common Stock | $3.5b | $71.76 | -3.1% | 1.3M |
 NRIX | Nurix Therapeutics, Inc. Common stock | $2.4b | $22.66 | -1.3% | 851.1K |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $2.4b | $11.36 | -2.5% | 3.5M |
 SDGR | Schrodinger, Inc. Common Stock | $2.3b | $29.06 | -11.3% | 5.0M |
 DAWN | Day One Biopharmaceuticals, Inc. Common Stock | $2.2b | $21.52 | -0.0% | 3.0M |
 RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | $2.2b | $4.64 | -2.9% | 69.4M |
 TRVI | Trevi Therapeutics, Inc. Common Stock | $2.0b | $13.41 | -4.0% | 1.8M |
 ALVO | Alvotech Ordinary Shares | $1.9b | $6.18 | +0.7% | 1.2M |
 FTRE | Fortrea Holdings Inc. Common Stock | $1.9b | $20.77 | -1.4% | 2.3M |
 ABSI | Absci Corporation Common Stock | $1.9b | $10.34 | -10.9% | 5.5M |
 ZYME | Zymeworks Inc. | $1.8b | $25.57 | -2.0% | 471.4K |
 GENB | Generate Biomedicines, Inc. Common Stock | $1.8b | $14.10 | -0.9% | 1.1M |
 CERT | Certara, Inc. Common Stock | $1.4b | $9.20 | -7.9% | 3.3M |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.4b | $93.95 | -0.2% | 128.0K |
 TYRA | Tyra Biosciences, Inc. Common Stock | $1.4b | $20.71 | -3.5% | 640.4K |
 MRVI | Maravai LifeSciences Holdings, Inc. Class A Common Stock | $1.2b | $7.87 | -7.8% | 3.3M |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.2b | $16.54 | -4.3% | 874.4K |
 OPK | Opko Health Inc. | $1.2b | $1.48 | -7.0% | 2.2M |
 HROW | Harrow, Inc. Common Stock | $1.1b | $30.87 | -0.9% | 320.7K |
 VOR | Vor Biopharma Inc. Common Stock | $1.1b | $18.31 | -1.5% | 402.9K |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.0b | $24.77 | -1.2% | 349.1K |
 GLUE | Monte Rosa Therapeutics, Inc. Common Stock | $0.9b | $9.97 | -3.8% | 805.9K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $2.77 | -4.2% | 3.4M |
 DNA | Ginkgo Bioworks Holdings, Inc. | $0.8b | $12.37 | -17.3% | 12.9M |